Status:
COMPLETED
Automated Telephone Monitoring for Symptom Management
Lead Sponsor:
Michigan State University
Conditions:
Carcinoma
Eligibility:
All Genders
21+ years
Phase:
PHASE2
Brief Summary
To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 co...
Detailed Description
Overview: Prevalent symptoms among patients undergoing chemotherapy include: pain, fatigue, dry mouth, constipation, anorexia, nausea, sleep disturbance, shortness of breath or difficulty breathing, a...
Eligibility Criteria
Inclusion
- 21 years of age or older
- solid tumor cancer diagnosis
- receiving chemotherapy treatment
Exclusion
- Emotional or psychology disorder for which patient is receiving treatment
- does not speak English
- does not have access to a telephone
- difficulty hearing on the telephone
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
526 Patients enrolled
Trial Details
Trial ID
NCT00799084
Start Date
April 1 2003
End Date
November 1 2006
Last Update
December 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan State University
East Lansing, Michigan, United States, 48824